Recognition of the antigen-presenting molecule MR1 by a Vδ3
Adult
Antigen Presentation
Female
Histocompatibility Antigens Class I
/ immunology
Humans
Intraepithelial Lymphocytes
/ metabolism
Ligands
Male
Minor Histocompatibility Antigens
/ chemistry
Mucosal-Associated Invariant T Cells
/ immunology
Receptors, Antigen, T-Cell
/ immunology
Receptors, Antigen, T-Cell, alpha-beta
/ metabolism
Receptors, Antigen, T-Cell, gamma-delta
/ immunology
MR1
structural immunology
γδTCR
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
07 12 2021
07 12 2021
Historique:
accepted:
20
10
2021
entrez:
30
11
2021
pubmed:
1
12
2021
medline:
19
1
2022
Statut:
ppublish
Résumé
Unlike conventional αβ T cells, γδ T cells typically recognize nonpeptide ligands independently of major histocompatibility complex (MHC) restriction. Accordingly, the γδ T cell receptor (TCR) can potentially recognize a wide array of ligands; however, few ligands have been described to date. While there is a growing appreciation of the molecular bases underpinning variable (V)δ1
Identifiants
pubmed: 34845016
pii: 2110288118
doi: 10.1073/pnas.2110288118
pmc: PMC8694053
pii:
doi:
Substances chimiques
Histocompatibility Antigens Class I
0
Ligands
0
MR1 protein, human
0
Minor Histocompatibility Antigens
0
Receptors, Antigen, T-Cell
0
Receptors, Antigen, T-Cell, alpha-beta
0
Receptors, Antigen, T-Cell, gamma-delta
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI148407
Pays : United States
Déclaration de conflit d'intérêts
Competing interest statement: J.R. is an inventor on patents describing MR1 tetramers and MR1 ligands.
Références
Science. 2005 Apr 8;308(5719):227-31
pubmed: 15821084
Immunity. 2016 Jan 19;44(1):32-45
pubmed: 26795251
J Synchrotron Radiat. 2002 Nov 1;9(Pt 6):401-6
pubmed: 12409628
J Exp Med. 1990 May 1;171(5):1597-612
pubmed: 2185330
Nat Immunol. 2020 Apr;21(4):400-411
pubmed: 32123373
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nat Commun. 2017 Mar 01;8:14760
pubmed: 28248310
Nature. 2014 May 15;509(7500):361-5
pubmed: 24695216
Cell Mol Immunol. 2013 Jan;10(1):50-7
pubmed: 23064104
Eur J Immunol. 1991 Apr;21(4):1053-9
pubmed: 1826884
Nat Immunol. 2016 May;17(5):531-7
pubmed: 27043408
Scand J Immunol. 1989 Jul;30(1):123-8
pubmed: 2526965
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
J Exp Med. 2000 Sep 4;192(5):741-54
pubmed: 10974039
Nature. 1998 Jan 29;391(6666):502-6
pubmed: 9461220
Methods. 2011 Sep;55(1):94-106
pubmed: 21821126
J Exp Med. 2008 May 12;205(5):1201-11
pubmed: 18443227
Clin Exp Immunol. 1994 Oct;98(1):78-82
pubmed: 7923889
PLoS One. 2013 Oct 04;8(10):e76008
pubmed: 24124528
Mediators Inflamm. 1999;8(6):305-12
pubmed: 10815619
Eur J Immunol. 1993 Apr;23(4):804-8
pubmed: 8384559
Nat Commun. 2019 May 21;10(1):2243
pubmed: 31113973
Blood. 2011 Jul 28;118(4):992-1001
pubmed: 21633088
J Immunol. 1994 Nov 1;153(9):3979-88
pubmed: 7930606
Nat Immunol. 2010 Aug;11(8):701-8
pubmed: 20581831
Nat Immunol. 2012 Sep;13(9):872-9
pubmed: 22885985
J Exp Med. 1991 Jun 1;173(6):1311-22
pubmed: 1827824
Science. 1998 Mar 13;279(5357):1737-40
pubmed: 9497295
Immunology. 2009 Feb;126(2):147-64
pubmed: 19125886
J Clin Invest. 1999 May 15;103(10):1437-49
pubmed: 10330426
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):E556-65
pubmed: 25617367
J Exp Med. 2013 Oct 21;210(11):2305-20
pubmed: 24101382
Nat Immunol. 2013 Nov;14(11):1137-45
pubmed: 24076636
Nat Rev Immunol. 2015 Nov;15(11):683-91
pubmed: 26449179
Mediators Inflamm. 2001 Aug;10(4):179-89
pubmed: 11577994
J Immunol. 2013 Jul 1;191(1):30-4
pubmed: 23740951
Immunol Rev. 2007 Feb;215:59-76
pubmed: 17291279
Nat Commun. 2018 Nov 9;9(1):4706
pubmed: 30413689
Nat Immunol. 2017 Apr;18(4):402-411
pubmed: 28166217
Immunity. 2014 Apr 17;40(4):490-500
pubmed: 24703779
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3163-3168
pubmed: 28270598
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22944-22952
pubmed: 32868441
Blood. 2012 Apr 26;119(17):4013-6
pubmed: 22403253
Science. 2020 Feb 7;367(6478):
pubmed: 31919129
Science. 2019 Dec 20;366(6472):1522-1527
pubmed: 31857486
Nat Commun. 2013;4:2142
pubmed: 23846752
Nat Commun. 2018 May 2;9(1):1760
pubmed: 29720665
Biochem Soc Trans. 2021 Nov 1;49(5):1985-1995
pubmed: 34515758
J Exp Med. 2014 Jul 28;211(8):1585-600
pubmed: 25049336
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Nature. 2012 Nov 29;491(7426):717-23
pubmed: 23051753
Blood. 2011 Dec 22;118(26):6952-62
pubmed: 22045985
Immunity. 2013 Dec 12;39(6):1032-42
pubmed: 24239091
Immunity. 2012 Sep 21;37(3):524-34
pubmed: 22960222
Nat Immunol. 2020 Feb;21(2):178-185
pubmed: 31959982
Sci Immunol. 2018 Dec 14;3(30):
pubmed: 30552102
Nat Commun. 2014 May 15;5:3866
pubmed: 24832684
J Invest Dermatol. 1990 Jan;94(1):37-42
pubmed: 1688597
Trends Immunol. 2018 Jun;39(6):446-459
pubmed: 29680462
J Biol Chem. 2020 Oct 16;295(42):14445-14457
pubmed: 32817339
Int Immunol. 1999 Apr;11(4):545-52
pubmed: 10323207
Nat Rev Immunol. 2013 Feb;13(2):88-100
pubmed: 23348415
J Immunol. 2015 Mar 1;194(5):2390-8
pubmed: 25637025
PLoS Biol. 2010 Jun 29;8(6):e1000407
pubmed: 20613858
J Immunol. 2016 Feb 15;196(4):1933-42
pubmed: 26755823
Blood. 2012 Sep 13;120(11):2269-79
pubmed: 22767497
Nat Immunol. 2018 Apr;19(4):397-406
pubmed: 29531339
Eur J Immunol. 2012 Sep;42(9):2505-10
pubmed: 22829134
Nat Immunol. 2015 Mar;16(3):258-66
pubmed: 25642819